These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 23029549)

  • 21. Regulation of cardiac fatty acids metabolism in transgenic mice overexpressing bovine GH.
    Bogazzi F; Raggi F; Ultimieri F; Russo D; D'Alessio A; Manariti A; Brogioni S; Manetti L; Martino E
    J Endocrinol; 2009 Jun; 201(3):419-27. PubMed ID: 19342398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic inhibition of pyruvate dehydrogenase in heart triggers an adaptive metabolic response.
    Chambers KT; Leone TC; Sambandam N; Kovacs A; Wagg CS; Lopaschuk GD; Finck BN; Kelly DP
    J Biol Chem; 2011 Apr; 286(13):11155-62. PubMed ID: 21321124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Redox state-dependent and sorbitol accumulation-independent diabetic albuminuria in mice with transgene-derived human aldose reductase and sorbitol dehydrogenase deficiency.
    Ii S; Ohta M; Kudo E; Yamaoka T; Tachikawa T; Moritani M; Itakura M; Yoshimoto K
    Diabetologia; 2004 Mar; 47(3):541-548. PubMed ID: 14968292
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic and Cardiac Adaptation to Chronic Pharmacologic Blockade of Facilitative Glucose Transport in Murine Dilated Cardiomyopathy and Myocardial Ischemia.
    Heitmeier MR; Payne MA; Weinheimer C; Kovacs A; Hresko RC; Jay PY; Hruz PW
    Sci Rep; 2018 Apr; 8(1):6475. PubMed ID: 29691457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiomyocyte-specific ablation of CD36 improves post-ischemic functional recovery.
    Nagendran J; Pulinilkunnil T; Kienesberger PC; Sung MM; Fung D; Febbraio M; Dyck JR
    J Mol Cell Cardiol; 2013 Oct; 63():180-8. PubMed ID: 23948483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic activation of PPARalpha is detrimental to cardiac recovery after ischemia.
    Sambandam N; Morabito D; Wagg C; Finck BN; Kelly DP; Lopaschuk GD
    Am J Physiol Heart Circ Physiol; 2006 Jan; 290(1):H87-95. PubMed ID: 16155108
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aldose reductase inhibition protects diabetic and nondiabetic rat hearts from ischemic injury.
    Ramasamy R; Oates PJ; Schaefer S
    Diabetes; 1997 Feb; 46(2):292-300. PubMed ID: 9000707
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rescue of cardiomyopathy in peroxisome proliferator-activated receptor-alpha transgenic mice by deletion of lipoprotein lipase identifies sources of cardiac lipids and peroxisome proliferator-activated receptor-alpha activators.
    Duncan JG; Bharadwaj KG; Fong JL; Mitra R; Sambandam N; Courtois MR; Lavine KJ; Goldberg IJ; Kelly DP
    Circulation; 2010 Jan; 121(3):426-35. PubMed ID: 20065164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiomyocyte-specific loss of diacylglycerol acyltransferase 1 (DGAT1) reproduces the abnormalities in lipids found in severe heart failure.
    Liu L; Trent CM; Fang X; Son NH; Jiang H; Blaner WS; Hu Y; Yin YX; Farese RV; Homma S; Turnbull AV; Eriksson JW; Hu SL; Ginsberg HN; Huang LS; Goldberg IJ
    J Biol Chem; 2014 Oct; 289(43):29881-91. PubMed ID: 25157099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Altered oxido-reductive state in the diabetic heart: loss of cardioprotection due to protein disulfide isomerase.
    Toldo S; Boccellino M; Rinaldi B; Seropian IM; Mezzaroma E; Severino A; Quagliuolo L; Van Tassell BW; Marfella R; Paolisso G; Rossi F; Natarajan R; Voelkel N; Abbate A; Crea F; Baldi A
    Mol Med; 2011; 17(9-10):1012-21. PubMed ID: 21637911
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aldose reductase activation is a key component of myocardial response to ischemia.
    Hwang YC; Sato S; Tsai JY; Yan S; Bakr S; Zhang H; Oates PJ; Ramasamy R
    FASEB J; 2002 Feb; 16(2):243-5. PubMed ID: 11772943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preservation of Acyl Coenzyme A Attenuates Pathological and Metabolic Cardiac Remodeling Through Selective Lipid Trafficking.
    Goldenberg JR; Carley AN; Ji R; Zhang X; Fasano M; Schulze PC; Lewandowski ED
    Circulation; 2019 Jun; 139(24):2765-2777. PubMed ID: 30909726
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD36 deficiency rescues lipotoxic cardiomyopathy.
    Yang J; Sambandam N; Han X; Gross RW; Courtois M; Kovacs A; Febbraio M; Finck BN; Kelly DP
    Circ Res; 2007 Apr; 100(8):1208-17. PubMed ID: 17363697
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aldose reductase modulates acute activation of mesenchymal markers via the β-catenin pathway during cardiac ischemia-reperfusion.
    Thiagarajan D; O' Shea K; Sreejit G; Ananthakrishnan R; Quadri N; Li Q; Schmidt AM; Gabbay K; Ramasamy R
    PLoS One; 2017; 12(11):e0188981. PubMed ID: 29190815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of c-Jun-N-terminal kinase increases cardiac peroxisome proliferator-activated receptor alpha expression and fatty acid oxidation and prevents lipopolysaccharide-induced heart dysfunction.
    Drosatos K; Drosatos-Tampakaki Z; Khan R; Homma S; Schulze PC; Zannis VI; Goldberg IJ
    J Biol Chem; 2011 Oct; 286(42):36331-9. PubMed ID: 21873422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. cGMP-Elevating Compounds and Ischemic Conditioning Provide Cardioprotection Against Ischemia and Reperfusion Injury via Cardiomyocyte-Specific BK Channels.
    Frankenreiter S; Bednarczyk P; Kniess A; Bork NI; Straubinger J; Koprowski P; Wrzosek A; Mohr E; Logan A; Murphy MP; Gawaz M; Krieg T; Szewczyk A; Nikolaev VO; Ruth P; Lukowski R
    Circulation; 2017 Dec; 136(24):2337-2355. PubMed ID: 29051185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The protective effect of trimetazidine on myocardial ischemia/reperfusion injury through activating AMPK and ERK signaling pathway.
    Liu Z; Chen JM; Huang H; Kuznicki M; Zheng S; Sun W; Quan N; Wang L; Yang H; Guo HM; Li J; Zhuang J; Zhu P
    Metabolism; 2016 Mar; 65(3):122-30. PubMed ID: 26892523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of the peroxisome proliferator-activated receptor alpha pathway in pathological remodeling of the diabetic heart.
    Finck BN
    Curr Opin Clin Nutr Metab Care; 2004 Jul; 7(4):391-6. PubMed ID: 15192440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiomyocyte expression of PPARgamma leads to cardiac dysfunction in mice.
    Son NH; Park TS; Yamashita H; Yokoyama M; Huggins LA; Okajima K; Homma S; Szabolcs MJ; Huang LS; Goldberg IJ
    J Clin Invest; 2007 Oct; 117(10):2791-801. PubMed ID: 17823655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of glutaredoxin-2 reduces myocardial cell death by preventing both apoptosis and necrosis.
    Nagy N; Malik G; Tosaki A; Ho YS; Maulik N; Das DK
    J Mol Cell Cardiol; 2008 Feb; 44(2):252-60. PubMed ID: 18076901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.